Aemetis Competitors

Aemetis (NASDAQ:AMTX) and LyondellBasell Industries (NYSE:LYB) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Insider & Institutional Ownership

12.9% of Aemetis shares are held by institutional investors. Comparatively, 67.6% of LyondellBasell Industries shares are held by institutional investors. 28.3% of Aemetis shares are held by insiders. Comparatively, 0.2% of LyondellBasell Industries shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Aemetis and LyondellBasell Industries, as provided by MarketBeat.com.

LyondellBasell Industries has a consensus price target of $76.4091, suggesting a potential downside of 25.88%. Given Aemetis' stronger consensus rating and higher probable upside, research analysts clearly believe Aemetis is more favorable than LyondellBasell Industries.

Earnings & Valuation

This table compares Aemetis and LyondellBasell Industries' top-line revenue, earnings per share and valuation.

LyondellBasell Industries has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than LyondellBasell Industries, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Aemetis has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, LyondellBasell Industries has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500.

Profitability

This table compares Aemetis and LyondellBasell Industries' net margins, return on equity and return on assets.

Summary

LyondellBasell Industries beats Aemetis on 10 of the 14 factors compared between the two stocks.

Aemetis (NASDAQ:AMTX) and International Flavors & Fragrances (NYSE:IFF) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Insider & Institutional Ownership

12.9% of Aemetis shares are held by institutional investors. Comparatively, 94.4% of International Flavors & Fragrances shares are held by institutional investors. 28.3% of Aemetis shares are held by insiders. Comparatively, 0.4% of International Flavors & Fragrances shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Aemetis and International Flavors & Fragrances, as provided by MarketBeat.com.

International Flavors & Fragrances has a consensus price target of $141.1167, suggesting a potential upside of 4.14%. Given International Flavors & Fragrances' higher probable upside, analysts clearly believe International Flavors & Fragrances is more favorable than Aemetis.

Earnings & Valuation

This table compares Aemetis and International Flavors & Fragrances' top-line revenue, earnings per share and valuation.

International Flavors & Fragrances has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than International Flavors & Fragrances, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Aemetis has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, International Flavors & Fragrances has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500.

Profitability

This table compares Aemetis and International Flavors & Fragrances' net margins, return on equity and return on assets.

Summary

International Flavors & Fragrances beats Aemetis on 12 of the 14 factors compared between the two stocks.

Aemetis (NASDAQ:AMTX) and Westlake Chemical (NYSE:WLK) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Insider & Institutional Ownership

12.9% of Aemetis shares are held by institutional investors. Comparatively, 28.2% of Westlake Chemical shares are held by institutional investors. 28.3% of Aemetis shares are held by insiders. Comparatively, 73.1% of Westlake Chemical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Aemetis and Westlake Chemical, as provided by MarketBeat.com.

Westlake Chemical has a consensus price target of $69.5333, suggesting a potential downside of 18.76%. Given Aemetis' stronger consensus rating and higher probable upside, research analysts clearly believe Aemetis is more favorable than Westlake Chemical.

Earnings & Valuation

This table compares Aemetis and Westlake Chemical's top-line revenue, earnings per share and valuation.

Westlake Chemical has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than Westlake Chemical, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Aemetis has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, Westlake Chemical has a beta of 1.62, meaning that its share price is 62% more volatile than the S&P 500.

Profitability

This table compares Aemetis and Westlake Chemical's net margins, return on equity and return on assets.

Summary

Westlake Chemical beats Aemetis on 12 of the 14 factors compared between the two stocks.

Aemetis (NASDAQ:AMTX) and Braskem (NYSE:BAK) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Insider & Institutional Ownership

12.9% of Aemetis shares are held by institutional investors. Comparatively, 0.5% of Braskem shares are held by institutional investors. 28.3% of Aemetis shares are held by insiders. Comparatively, 0.0% of Braskem shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Aemetis and Braskem, as provided by MarketBeat.com.

Braskem has a consensus price target of $14.00, suggesting a potential upside of 24.44%. Given Braskem's higher probable upside, analysts clearly believe Braskem is more favorable than Aemetis.

Earnings & Valuation

This table compares Aemetis and Braskem's top-line revenue, earnings per share and valuation.

Aemetis has higher earnings, but lower revenue than Braskem. Braskem is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Aemetis has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, Braskem has a beta of 1.36, meaning that its share price is 36% more volatile than the S&P 500.

Profitability

This table compares Aemetis and Braskem's net margins, return on equity and return on assets.

Aemetis (NASDAQ:AMTX) and NewMarket (NYSE:NEU) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Insider & Institutional Ownership

12.9% of Aemetis shares are held by institutional investors. Comparatively, 55.7% of NewMarket shares are held by institutional investors. 28.3% of Aemetis shares are held by insiders. Comparatively, 16.9% of NewMarket shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Aemetis and NewMarket, as provided by MarketBeat.com.

Given Aemetis' higher probable upside, research analysts clearly believe Aemetis is more favorable than NewMarket.

Earnings & Valuation

This table compares Aemetis and NewMarket's top-line revenue, earnings per share and valuation.

NewMarket has higher revenue and earnings than Aemetis.

Volatility & Risk

Aemetis has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, NewMarket has a beta of 0.41, meaning that its share price is 59% less volatile than the S&P 500.

Profitability

This table compares Aemetis and NewMarket's net margins, return on equity and return on assets.

Summary

NewMarket beats Aemetis on 9 of the 12 factors compared between the two stocks.

Aemetis (NASDAQ:AMTX) and Sensient Technologies (NYSE:SXT) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Earnings & Valuation

This table compares Aemetis and Sensient Technologies' top-line revenue, earnings per share and valuation.

Sensient Technologies has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than Sensient Technologies, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Aemetis and Sensient Technologies, as provided by MarketBeat.com.

Sensient Technologies has a consensus price target of $70.00, suggesting a potential downside of 10.08%. Given Aemetis' higher probable upside, research analysts clearly believe Aemetis is more favorable than Sensient Technologies.

Insider & Institutional Ownership

12.9% of Aemetis shares are held by institutional investors. Comparatively, 88.9% of Sensient Technologies shares are held by institutional investors. 28.3% of Aemetis shares are held by insiders. Comparatively, 0.8% of Sensient Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Aemetis and Sensient Technologies' net margins, return on equity and return on assets.

Volatility & Risk

Aemetis has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, Sensient Technologies has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500.

Summary

Sensient Technologies beats Aemetis on 10 of the 12 factors compared between the two stocks.